Skip to main content

Invokana Plaintiffs To Submit Documents For Pending Claims

Invokana Plaintiffs To Submit Documents For Pending Claims

Invokana Plaintiffs To Submit Documents For Pending Claims

Introduction

In an order issued on August 16, Judge Martinotti presiding over Invokana lawsuits, instructed the plaintiffs whose claims remain unresolved to submit additional information related to their case. For proceeding, the plaintiffs are also required to inform the treating doctors and dispensing pharmacies to save evidence, medical records and fact sheets related to their claims. The order also implies that the resolution process would come into effect immediately for new Invokana cases filed. However, existing plaintiffs get time till October 30 for submitting the additional documents and evidence.

Defendants Johnson & Johnson and its subsidiary Janssen Pharmaceuticals face hundreds of lawsuits claiming the manufacturers failed to send out an adequate public warning regarding the risk of amputations of the leg and foot as potential side effects of the diabetes drug. The federal multidistrict litigation (MDL No: 2750) for Invokana lawsuits was formed in December 2016, in the U.S. District Court, District of New Jersey, presided by Hon. Brian R. Martinotti for coordinated pretrial proceedings. The first bellwether trial is slated to begin in September 2018.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!